Hypersence is a digital health company bringing a patent-pending, non-drug treatment to 46M desperate Alzheimer's sufferers globally. Winner of Stanford's GIC accelerator "Chairman's Choice" award (Feb 2021). Now as easy as putting on glasses, AD sufferers can reduce the plaque in the brain that causes memory loss by up to 50%, in the comfort of their own home, without a prescription, in as little as twenty minutes a day.